Globe Newswire (Thu, 19-Feb 6:30 PM ET)
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
PRNewswire (Wed, 11-Feb 8:02 PM ET)
PRNewswire (Fri, 6-Feb 4:29 PM ET)
Business Wire (Thu, 5-Feb 5:30 PM ET)
Halper Sadeh LLC Reminds Shareholders of RAPT, PEN, CVGW, FONR of the Firm's Investigations
Globe Newswire (Mon, 2-Feb 5:49 PM ET)
Halper Sadeh LLC Reminds Shareholders of JHG, FOLD, RAPT of the Firm's Investigations
Globe Newswire (Mon, 2-Feb 4:49 PM ET)
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger--JHG, FOLD, RAPT, and EXAS
PRNewswire (Mon, 2-Feb 3:30 PM ET)
Globe Newswire (Thu, 29-Jan 12:28 PM ET)
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights
PRNewswire (Wed, 28-Jan 6:41 PM ET)
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA
PRNewswire (Wed, 28-Jan 2:23 PM ET)
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
Rapt Therapeutics trades on the NASDAQ stock market under the symbol RAPT.
As of March 6, 2026, RAPT stock price was flat at $58.02 with million shares trading.
RAPT has a beta of 1.49, meaning it tends to be more sensitive to market movements. RAPT has a correlation of 0.05 to the broad based SPY ETF.
RAPT has a market cap of $1.68 billion. This is considered a Small Cap stock.
In the last 3 years, RAPT traded as high as $246.56 and as low as $5.67.
The top ETF exchange traded funds that RAPT belongs to (by Net Assets): VTI, VXF.
RAPT has outperformed the market in the last year with a price return of +547.5% while the SPY ETF gained +18.7%. RAPT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +68.3% and +0.2%, respectively, while the SPY returned -1.7% and -2.5%, respectively.
RAPT support price is $57.96 and resistance is $58.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RAPT shares will trade within this expected range on the day.
